News Releases Year: All News201920182017201620152014201320122011 Items per page All News2550 February 10, 2016 Summary ToggleAllena Pharmaceuticals Initiates Patient Treatment in Third Phase 2 Trial of ALLN-177 for Secondary Hyperoxaluria Read more January 8, 2016 Summary ToggleAllena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference Read more December 5, 2015 Summary ToggleAllena Pharmaceuticals Raises $53 Million in Series C Financing Read more November 12, 2015 Summary ToggleAllena Pharmaceuticals Announces Presentation of Successful Phase 2 Data from ALLN-177 Program at American Society of Nephrology Kidney Week Read more November 4, 2015 Summary ToggleAllena Pharmaceuticals To Present Phase 2 Data on ALLN-177 Program at ASN Kidney Week 2015 Read more August 4, 2015 Summary ToggleAllena Pharmaceuticals Initiates Phase 2b Trial of ALLN-177 for Secondary Hyperoxaluria Read more April 16, 2015 Summary ToggleAllena Pharmaceuticals Appoints Louis Brenner, M.D. as Chief Operating Officer Read more March 18, 2015 Summary ToggleAllena Pharmaceuticals Announces Positive Phase 2a Data of ALLN-177 for the Treatment of Hyperoxaluria Read more January 8, 2015 Summary ToggleAllena Pharmaceuticals to Present at 2015 J.P. Morgan Healthcare Conference Read more December 4, 2014 Summary ToggleAllena Pharmaceuticals Secures $25 Million Series B Financing Read more Pagination First page First Previous page Previous … Page 2 Page 3 Current page 4 Page 5 Next page Next Last page Last
